Merck | MRK - Ebitda


Merck reported EUR1.53B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Adidas EUR 985M 517M Mar/2026
Adyen EUR 702.06M 158.36M Dec/2025
Akzo Nobel EUR 345M 540M Mar/2026
Alcon AG USD 795M 478M Mar/2026
Amadeus IT EUR 661.4M 83.5M Mar/2026
Amarin USD 12.54M 28.57M Jun/2025
AstraZeneca USD 5.67B 1.29B Mar/2026
BASF EUR 2.36B 217M Mar/2026
Bayer EUR 4.45B 2.49B Mar/2026
Beiersdorf EUR 984M 147M Jun/2025
Covestro EUR 117M 125M Dec/2025
Danone EUR 2.57B 116M Dec/2025
Fresenius EUR 951M 283M Mar/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
Genmab DKK 186M 291M Dec/2025
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
GRIFOLS EUR 347.45M 210K Dec/2025
Henkel EUR 1.88B 139M Dec/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Infineon EUR 1.1B 28M Mar/2026
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Linde USD 3.38B 30M Sep/2025
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.53B 87M Mar/2026
Novartis USD 5.3B 530M Mar/2026
Philips EUR 567M 233M Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
UCB EUR 1.6B 570M Dec/2025